Literature DB >> 17765042

Evaluation of the adult with suspected immunodeficiency.

Antoine E Azar1, Zuhair K Ballas.   

Abstract

Several primary immunodeficiencies may have their initial presentation in adulthood. Although recurrent infections are the hallmark of an underlying immunodeficiency, they need not be the presenting manifestation. This review highlights aspects of infections, as well as noninfectious diseases, that should prompt a high index of suspicion for an underlying immune disorder. The office tests that can be obtained for initial screening and their interpretation are detailed.

Entities:  

Mesh:

Year:  2007        PMID: 17765042     DOI: 10.1016/j.amjmed.2006.12.013

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  9 in total

Review 1.  Patient-centred screening for primary immunodeficiency, a multi-stage diagnostic protocol designed for non-immunologists: 2011 update.

Authors:  E de Vries
Journal:  Clin Exp Immunol       Date:  2012-01       Impact factor: 4.330

2.  Genetic polymorphism study of regulatory B cell molecules and cellular immunity function in an adult patient with Common Variable Immunodeficiency.

Authors:  A Sarantopoulos; K Tselios; P Skendros; D Bougiouklis; I Theodorou; P Boura
Journal:  Hippokratia       Date:  2008-07       Impact factor: 0.471

3.  Invasive pseudomembranous upper airway and tracheal Aspergillosis refractory to systemic antifungal therapy and serial surgical debridement in an Immunocompetent patient.

Authors:  Shihan N Khan; Rashmi Manur; John S Brooks; Michael A Husson; Kevin Leahy; Matthew Grant
Journal:  BMC Infect Dis       Date:  2020-01-06       Impact factor: 3.090

Review 4.  Recurrent Sinopulmonary Infections in a Patient Whose HIV Masked Common Variable Immunodeficiency.

Authors:  D Gollapudi; M O'Donnell; M NeSmith; K Kent; A J Hunter
Journal:  J Gen Intern Med       Date:  2020-01       Impact factor: 5.128

Review 5.  Is dosing of therapeutic immunoglobulins optimal? A review of a three-decade long debate in europe.

Authors:  Jacqueline Kerr; Isabella Quinti; Martha Eibl; Helen Chapel; Peter J Späth; W A Carrock Sewell; Abdulgabar Salama; Ivo N van Schaik; Taco W Kuijpers; Hans-Hartmut Peter
Journal:  Front Immunol       Date:  2014-12-12       Impact factor: 7.561

6.  Antibody deficiency in patients with frequent exacerbations of Chronic Obstructive Pulmonary Disease (COPD).

Authors:  Brian N McCullagh; Alejandro P Comellas; Zuhair K Ballas; John D Newell; M Bridget Zimmerman; Antoine E Azar
Journal:  PLoS One       Date:  2017-02-17       Impact factor: 3.240

7.  Effects of Immunoglobulin Replacement on Asthma Exacerbation in Adult Asthmatics with IgG Subclass Deficiency.

Authors:  Joo Hee Kim; Young Min Ye; Ga Young Ban; Yoo Seob Shin; Hyun Young Lee; Young Hee Nam; Soo Keol Lee; You Sook Cho; Seung Hun Jang; Ki Suck Jung; Hae Sim Park
Journal:  Allergy Asthma Immunol Res       Date:  2017-11       Impact factor: 5.764

8.  Diagnostic challenges of respiratory adverse events during everolimus treatment.

Authors:  Annelieke E C A B Willemsen; Filip Y De Vos; Anne Jansen; Maaike de Boer; Vivianne C G Tjan-Heijnen; Carla M L van Herpen
Journal:  Target Oncol       Date:  2014-03-05       Impact factor: 4.864

9.  Clinical Features and Outcomes of Pasteurella multocida Infection.

Authors:  Antonio Giordano; Toros Dincman; Benjamin E Clyburn; Lisa L Steed; Don C Rockey
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.